GENEVA, Sept. 7 -- NEW LIFE MEDICINE TECHNOLOGY COMPANY LIMITED filed a patent application (CN2026/079174) for “PH RESPONSIVE SPERMINE-LOADED HYDROGELS AND USES THEREOF FOR TREATING AND DIAGNOSING LOCALIZED PROSTATE CANCER”. With publication no. WO/2026/179793, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 9/06
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....